| DIPYRIDAMOLE | Small molecule | coronary artery disease | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | - | DailyMed |
| DIPYRIDAMOLE | Small molecule | internal carotid artery stenosis | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | angina pectoris | Equilibrative nucleoside transporter 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | heart disease | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | Recurrent thrombophlebitis | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | - | ATC |
| DIPYRIDAMOLE | Small molecule | COVID-19 | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | rheumatoid arthritis | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | Myocardial Ischemia | Equilibrative nucleoside transporter 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | COVID-19 | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | stroke | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | diabetes mellitus | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | pancreatic carcinoma | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | sickle cell anemia | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | serum lipopolysaccharide activity | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | ovarian cancer | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | bipolar disorder | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | coronary artery disease | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | ischemia reperfusion injury | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | coronary artery disease | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | COVID-19 | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | hypertension | Equilibrative nucleoside transporter 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | rheumatoid arthritis | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | Henoch-Schoenlein purpura | Equilibrative nucleoside transporter 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | Takotsubo cardiomyopathy | Equilibrative nucleoside transporter 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | HIV infection | Equilibrative nucleoside transporter 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | stroke | Equilibrative nucleoside transporter 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | cervical artery dissection | Equilibrative nucleoside transporter 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | COVID-19 | Equilibrative nucleoside transporter 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| DIPYRIDAMOLE | Small molecule | stroke | Equilibrative nucleoside transporter 1 inhibitor | 4.0 | - | DailyMed |